We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Ultra-Portable Rapid Test Platform Offers Complete Sample-to-Answer Solution for Remote and Off-Grid Testing

By LabMedica International staff writers
Posted on 07 Jun 2023

An ultra-portable isothermal molecular diagnostics system integrated with a patented device which combines sample collection and processing into a single, easy-to-use disposable is set to revolutionize low-cost decentralized diagnostic testing. More...

ReadyGo Diagnostics’ (Bath, UK) Geo is a rapid test platform designed for small labs, pharmacies, and remote diagnostic needs. This highly portable device enables molecular tests to be run anywhere and delivers results in approximately 20 minutes. Designed to go anywhere, Geo uses ReadyGo’s Flex reagents which do not require cold-chain, making it a true off-grid, go-anywhere test platform. The platform also does not require a specialized operator or accurate pipetting thanks to its pre-measured reagents.

Combined with ReadyGo's innovative sample collection device, Snap, Geo offers a comprehensive solution for remote and off-grid testing of up to eight samples simultaneously. Snap, a compact, single-use device about the size of a highlighter pen, integrates sample collection and preparation. It uses a specialized material to absorb a specified amount of the patient's sample via capillary action, which is then mixed with a dried lysis reagent stored within the device. The reagent's components are similar to those in mouthwash, safe for human use, and highly effective at breaking down pathogens without inhibiting nucleic acid amplification reactions.

Operating the Snap device is simple: the user collects a sample, and bends the device to break an internal valve, releasing the exact amount of buffer required for the reaction into the chamber. Then, the user simply squeezes the bulb on the end of the device to release the contents for diagnostic testing. This simple sample preparation method also reduces the cost of the diagnostic assay, as it does not require any moving components. Snap eliminates the buffer measuring step, which some users found challenging when using over-the-counter lateral flow COVID-19 tests. When paired with Geo's eight-well isothermal amplification platform, the user can directly transfer Snap's contents into tubes pre-filled with assay reagents, then place the tubes in the Geo instrument for amplification and reading. Snap can be used with various samples, including saliva, nasal, buccal, and even surface samples, with ReadyGo also developing options for blood, urine, and stool sample collection.

ReadyGo has designed tests using recombinase polymerase amplification (RPA) and loop-mediated isothermal amplification (LAMP) for Geo's isothermal amplification and is currently developing its proprietary chemistry. The Geo platform is expected to be priced under USD 1,000, with individual assays costing around USD 10, making it a low-cost diagnostic solution for small labs and research groups. Additionally, the Geo system is designed for 3D printing in its manufacturing process, in line with ReadyGo’s goal to decentralize production and commercialization. This design will allow the system to be produced locally wherever testing is required and also provide the benefit of lower assembly costs in various parts of the world. The Geo system's streamlined design also reduces the need for plastics in its construction. ReadyGo aims to collaborate with other labs and companies, as well as develop tests that can be commercialized by its partners.

Related Links:
ReadyGo Diagnostics 


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.